Published in Aliment Pharmacol Ther on February 01, 2003
Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis. Gut (2008) 1.75
Gastrointestinal transit, release and plasma pharmacokinetics of a new oral budesonide formulation. Br J Clin Pharmacol (2006) 1.22
Emerging drugs for the treatment of ulcerative colitis. Expert Opin Emerg Drugs (2009) 0.87
5-ASA in ulcerative colitis: improving treatment compliance. World J Gastroenterol (2009) 0.80
Long-term efficacy and safety of once-daily mesalazine granules for the treatment of active ulcerative colitis. Clin Exp Gastroenterol (2014) 0.79
A dynamic model of once-daily 5-aminosalicylic acid predicts clinical efficacy. World J Gastroenterol (2010) 0.78
Release of 5-Aminosalicylic Acid (5-ASA) from Mesalamine Formulations at Various pH Levels. Adv Ther (2015) 0.78
Maintaining remission in ulcerative colitis--role of once daily extended-release mesalamine. Drug Des Devel Ther (2011) 0.76
Overcoming adherence issues in ulcerative colitis. Gastroenterol Hepatol (N Y) (2007) 0.76
Patient considerations in the management of ulcerative colitis: role of once-daily MMX mesalamine. Patient Prefer Adherence (2009) 0.75
Systemic absorption of rifamycin SV MMX administered as modified-release tablets in healthy volunteers. Antimicrob Agents Chemother (2011) 0.75
Dissolution of Commercially Available Mesalamine Formulations at Various pH Levels. Drugs R D (2015) 0.75
Comparison of efficacy of multimatrix mesalazine 4.8 g/day once-daily with other high-dose mesalazine in active ulcerative colitis: a randomized, double-blind study. Intest Res (2017) 0.75
Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J Neurochem (1979) 5.92
The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J (1999) 5.47
The hydrogen hypothesis for the first eukaryote. Nature (1998) 5.26
Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion? Nat Med (1996) 5.09
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell (1998) 4.77
A modified procedure for the rapid preparation of efficiently transporting vesicles from small intestinal brush border membranes. Their use in investigating some properties of D-glucose and choline transport systems. Biochim Biophys Acta (1978) 4.66
Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway. Nature (1993) 4.20
The structure of the Antennapedia homeodomain determined by NMR spectroscopy in solution: comparison with prokaryotic repressors. Cell (1989) 4.13
Peroxisome proliferator-activated receptor alpha target genes. Cell Mol Life Sci (2004) 3.86
High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both alpha and gamma interferons. Proc Natl Acad Sci U S A (1991) 3.83
Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res (1996) 3.77
Lysosomes of the arterial wall. I. Isolation and subcellular fractionation of cells from normal rabbit aorta. J Exp Med (1972) 3.73
Protein--DNA contacts in the structure of a homeodomain--DNA complex determined by nuclear magnetic resonance spectroscopy in solution. EMBO J (1990) 3.50
Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol (2008) 3.18
The interaction with DNA of wild-type and mutant fushi tarazu homeodomains. EMBO J (1990) 2.97
Hydrogenosome, a cytoplasmic organelle of the anaerobic flagellate Tritrichomonas foetus, and its role in pyruvate metabolism. J Biol Chem (1973) 2.90
Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology (1999) 2.61
DNA binding properties of the purified Antennapedia homeodomain. Proc Natl Acad Sci U S A (1990) 2.60
A novel sec-independent periplasmic protein translocation pathway in Escherichia coli. EMBO J (1998) 2.57
Role of tissue factor in embryonic blood vessel development. Nature (1996) 2.54
Universal digital quantum simulation with trapped ions. Science (2011) 2.49
In vitro translocation of bacterial proteins across the plasma membrane of Escherichia coli. Proc Natl Acad Sci U S A (1984) 2.46
Nuclear magnetic resonance solution structure of the fushi tarazu homeodomain from Drosophila and comparison with the Antennapedia homeodomain. J Mol Biol (1994) 2.43
Lymphocytic and granulomatous hypophysitis: experience with nine cases. Neurosurgery (1997) 2.37
Protein export in Escherichia coli requires a soluble activity. Proc Natl Acad Sci U S A (1984) 2.34
Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest (1994) 2.30
Determination of the nuclear magnetic resonance solution structure of an Antennapedia homeodomain-DNA complex. J Mol Biol (1993) 2.20
Partial impairment of cytokine responses in Tyk2-deficient mice. Immunity (2000) 2.17
Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther (1994) 2.14
Proviral load determination of different feline immunodeficiency virus isolates using real-time polymerase chain reaction: influence of mismatches on quantification. Electrophoresis (1999) 2.09
Three metronidazole-resistant strains of Trichomonas vaginalis from the United States. Am J Obstet Gynecol (1980) 2.06
Co-translocation of a periplasmic enzyme complex by a hitchhiker mechanism through the bacterial tat pathway. J Biol Chem (1999) 2.04
Retracted The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anesth Analg (1996) 2.04
Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles. Antimicrob Agents Chemother (1976) 2.04
Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes. J Virol (2001) 2.02
Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease. Lancet (1991) 2.02
High-pressure freezing of cell suspensions in cellulose capillary tubes. J Microsc (1994) 2.00
Insertion of proteins into bacterial membranes: mechanism, characteristics, and comparisons with the eucaryotic process. Microbiol Rev (1989) 1.99
In vivo biosynthesis of the vacuolar proteinases A and B in the yeast Saccharomyces cerevisiae. J Biol Chem (1982) 1.98
A bacterial secretory protein requires signal recognition particle for translocation across mammalian endoplasmic reticulum. J Biol Chem (1982) 1.97
Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling. J Exp Med (1996) 1.93
Retracted A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activity. Int J Cancer (1989) 1.93
Retracted Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class. Proc Natl Acad Sci U S A (1995) 1.93
The Fab-8 boundary defines the distal limit of the bithorax complex iab-7 domain and insulates iab-7 from initiation elements and a PRE in the adjacent iab-8 domain. Development (2000) 1.92
In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis. J Infect Dis (1986) 1.89
Secondary structure determination for the Antennapedia homeodomain by nuclear magnetic resonance and evidence for a helix-turn-helix motif. EMBO J (1988) 1.89
Lysosomes in Tetrahymena pyriformis. I. Some properties and lysosomal localization of acid hydrolases. J Cell Physiol (1966) 1.83
Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans. Antimicrob Agents Chemother (1996) 1.83
The structure of the homeodomain and its functional implications. Trends Genet (1990) 1.82
Foreign body reaction to meshes used for the repair of abdominal wall hernias. Eur J Surg (1999) 1.82
Detection of hepatitis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum. Hepatology (1999) 1.79
The homodimeric ATP-binding cassette transporter LmrA mediates multidrug transport by an alternating two-site (two-cylinder engine) mechanism. EMBO J (2000) 1.76
Asthma severity and medical resource utilisation. Eur Respir J (2004) 1.74
Chromatin domain boundaries in the Bithorax complex. Cell Mol Life Sci (1998) 1.74
High pressure freezing comes of age. Scanning Microsc Suppl (1989) 1.71
Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy. Am J Gastroenterol (2001) 1.70
Early-branching or fast-evolving eukaryotes? An answer based on slowly evolving positions. Proc Biol Sci (2000) 1.69
Skp, a molecular chaperone of gram-negative bacteria, is required for the formation of soluble periplasmic intermediates of outer membrane proteins. J Biol Chem (1999) 1.69
The functional integration of a polytopic membrane protein of Escherichia coli is dependent on the bacterial signal-recognition particle. Eur J Biochem (1995) 1.69
Discrimination between SRP- and SecA/SecB-dependent substrates involves selective recognition of nascent chains by SRP and trigger factor. EMBO J (2000) 1.68
Sequence close to the N-terminus of L2 protein is displayed on the surface of bovine papillomavirus type 1 virions. Virology (1997) 1.66
Circadian variation of granulocyte colony stimulating factor levels in man. Br J Haematol (1999) 1.65
Mucosal tolerance as therapy of type I allergy: intranasal application of recombinant Bet v 1, the major birch pollen allergen, leads to the suppression of allergic immune responses and airway inflammation in sensitized mice. Clin Exp Allergy (2002) 1.63
Uptake of metronidazole and its effect on viability in trichomonads and Entamoeba invadens under anaerobic and aerobic conditions. Antimicrob Agents Chemother (1976) 1.63
Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature (1993) 1.62
Identification of plant-associated enterococci. J Appl Microbiol (2001) 1.60
Specificity of signaling by STAT1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression. EMBO J (2001) 1.59
Continuous S-(+)-ketamine administration during elective coronary artery bypass graft surgery attenuates pro-inflammatory cytokine response during and after cardiopulmonary bypass. Br J Anaesth (2010) 1.59
Shrinking of polypropylene mesh in vivo: an experimental study in dogs. Eur J Surg (1998) 1.57
Intracellular neutral carrier-based Ca2+ microelectrode with subnanomolar detection limit. Pflugers Arch (1987) 1.57
Effects of hyperinsulinemia on plasma levels of circulating adhesion molecules. J Clin Endocrinol Metab (2000) 1.56
Penetration of moxifloxacin into peripheral compartments in humans. Antimicrob Agents Chemother (1999) 1.54
Biocompatibility of beta-stabilizing elements of titanium alloys. Biomaterials (2004) 1.54
Receptor for advanced glycation endproducts (RAGE) exhibits highly differential cellular and subcellular localisation in rat and human lung. Cell Mol Biol (Noisy-le-grand) (1998) 1.52
Specific gain- and loss-of-function phenotypes induced by satellite-specific DNA-binding drugs fed to Drosophila melanogaster. Mol Cell (2000) 1.52
bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice. Nat Med (1998) 1.50
Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock. Crit Care Med (2001) 1.50
Transgenic rat hearts expressing a human cardiac troponin T deletion reveal diastolic dysfunction and ventricular arrhythmias. Cardiovasc Res (2000) 1.50
Acetaminophen has greater antipyretic efficacy than aspirin in endotoxemia: a randomized, double-blind, placebo-controlled trial. Clin Pharmacol Ther (1999) 1.50
Distribution of tricarboxylic acid cycle enzymes and glyoxylate cycle enzymes between mitochondria and peroxisomes in Tetrahymena pyriformis. J Biol Chem (1968) 1.49
Organization of the major and minor capsid proteins in human papillomavirus type 33 virus-like particles. J Gen Virol (1995) 1.48
Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus. Exp Clin Endocrinol Diabetes (1997) 1.48
Determination of the three-dimensional structure of the Antennapedia homeodomain from Drosophila in solution by 1H nuclear magnetic resonance spectroscopy. J Mol Biol (1990) 1.47
Architecture and polymorphism of fibrillar supramolecular assemblies produced by in vitro aggregation of human calcitonin. J Struct Biol (1995) 1.47
Influence of different volume therapies on platelet function in the critically ill. Intensive Care Med (1996) 1.47
A randomized, placebo-controlled, double-blind crossover study of the effect of pentoxifylline on ocular fundus pulsations. Am J Ophthalmol (1996) 1.47
On the surface lattice of microtubules: helix starts, protofilament number, seam, and handedness. J Cell Biol (1986) 1.47
Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clin Pharmacol Ther (2000) 1.46
In vitro studies with purified components reveal signal recognition particle (SRP) and SecA/SecB as constituents of two independent protein-targeting pathways of Escherichia coli. Mol Biol Cell (1999) 1.46
Genotypic interaction and gender specificity of common genetic variants in the p53/mdm2 network in Crohn's disease. Digestion (2010) 1.45
Genes and cholestasis. Hepatology (2001) 1.45
Mitochondrial type iron-sulfur cluster assembly in the amitochondriate eukaryotes Trichomonas vaginalis and Giardia intestinalis, as indicated by the phylogeny of IscS. Mol Biol Evol (2001) 1.45
Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002. Diabetologia (2007) 1.45
Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. Blood (2000) 1.45
Inhalation scintigraphy with iodine-123-labeled interferon gamma-1b: pulmonary deposition and dose escalation study in healthy volunteers. J Nucl Med (1997) 1.44